Literature DB >> 35125734

Advances in HPV Screening Tests for Cervical Cancer-A Review.

Pesona Grace Lucksom1, Mingma Lhamu Sherpa2, Anup Pradhan1, Sunaina Lal2, Chamma Gupta2.   

Abstract

HPV is responsible for almost all cases of cervical cancer which in turn is one of the common causes of death among female genital malignancies. Cervical cancer being a preventable disease, screening plays a vital role in its reduction. In this era of advanced health care system and technologies this cancer is still in the increasing trend, especially in the Low and Middle Income Countries, which reflects the poor coverage of women for screening. Advances in screening tests and techniques for better and larger coverage of women is the need of the hour globally. Clinicians also need to be aware of the various promising technologies available for screening of cervical cancer precursors, application of which in general practice can be of immense help in cervical cancer reduction. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Advances; Cervical cancer; HPV; Screening; Techniques; Tests

Year:  2021        PMID: 35125734      PMCID: PMC8804131          DOI: 10.1007/s13224-021-01569-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  22 in total

1.  Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.

Authors:  A Pavani Sowjanya; Proma Paul; Haripriya Vedantham; Gayatri Ramakrishna; D Vidyadhari; K Vijayaraghavan; Shantha Laksmi; Mrudula Sudula; Brigitte M Ronnett; Manik Das; Keerti V Shah; Patti E Gravitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 2.  Cytology versus HPV testing for cervical cancer screening in the general population.

Authors:  George Koliopoulos; Victoria N Nyaga; Nancy Santesso; Andrew Bryant; Pierre Pl Martin-Hirsch; Reem A Mustafa; Holger Schünemann; Evangelos Paraskevaidis; Marc Arbyn
Journal:  Cochrane Database Syst Rev       Date:  2017-08-10

3.  A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study.

Authors:  Jerome L Belinson; Ruifang Wu; Suzanne E Belinson; Xinfeng Qu; Bin Yang; Hui Du; Ruosong Wu; Chun Wang; Lijie Zhang; Yanqiu Zhou; Ying Liu; Robert G Pretorius
Journal:  Am J Clin Pathol       Date:  2011-05       Impact factor: 2.493

Review 4.  The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.

Authors:  Li Yang; Yuanhang Zhu; Yang Bai; Xiaoan Zhang; Chenchen Ren
Journal:  J Cancer Res Ther       Date:  2017       Impact factor: 1.805

5.  The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.

Authors:  D A M Heideman; A T Hesselink; F J van Kemenade; T Iftner; J Berkhof; F Topal; D Agard; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

6.  Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach.

Authors:  Pooja Bansil; Scott Wittet; Jeanette L Lim; Jennifer L Winkler; Proma Paul; Jose Jeronimo
Journal:  BMC Public Health       Date:  2014-06-12       Impact factor: 3.295

7.  The application of deep learning based diagnostic system to cervical squamous intraepithelial lesions recognition in colposcopy images.

Authors:  Chunnv Yuan; Yeli Yao; Bei Cheng; Yifan Cheng; Ying Li; Yang Li; Xuechen Liu; Xiaodong Cheng; Xing Xie; Jian Wu; Xinyu Wang; Weiguo Lu
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

Review 8.  Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing.

Authors:  Yubo Fan; Yifan Meng; Shuo Yang; Ling Wang; Wenhua Zhi; Cordelle Lazare; Canhui Cao; Peng Wu
Journal:  Dis Markers       Date:  2018-11-14       Impact factor: 3.434

9.  Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening.

Authors:  Marion Saville; Farhana Sultana; Michael J Malloy; Louiza S Velentzis; Michael Caruana; Ellen L O Ip; Marco H T Keung; Karen Canfell; Julia M L Brotherton; David Hawkes
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

10.  The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings.

Authors:  Sasidharanpillai Sabeena; Santhosh Kuriakose; Damodaran Binesh; Jazeel Abdulmajeed; Giselle Dsouza; Amrutha Ramachandran; Bindu Vijaykumar; Sushama Aswathyraj; Santhosha Devadiga; Nagaraja Ravishankar; Govindakarnavar Arunkumar
Journal:  Asian Pac J Cancer Prev       Date:  2019-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.